Developing new statistical tools to understand COVID-19 and its long-term effects
Statistical Methods in COVID-19/PASC Clinical Research
['FUNDING_R01'] · MASSACHUSETTS GENERAL HOSPITAL · NIH-11038017
This study is looking at how COVID-19 affects people in the long run, especially those dealing with lingering symptoms, to find better ways to help them recover and improve their treatment options.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MASSACHUSETTS GENERAL HOSPITAL (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-11038017 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and testing innovative statistical methods to better understand the clinical aspects, biological factors, and social influences related to COVID-19 and its long-term effects, known as Post-Acute Sequelae of SARS-CoV-2 infection (PASC). By analyzing complex data from COVID-19 patients, the team aims to uncover the mechanisms that lead to PASC and improve recovery strategies. The project involves collaboration between physician-scientists and biostatisticians to ensure that the statistical tools developed are both clinically relevant and methodologically sound. Patients may benefit from improved understanding and treatment options as a result of this research.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced COVID-19 and are dealing with ongoing symptoms or complications.
Not a fit: Patients who have not been infected with COVID-19 or do not exhibit any long-term symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic and treatment strategies for patients suffering from long-term effects of COVID-19.
How similar studies have performed: Other research has shown promise in using advanced statistical methods to analyze COVID-19 data, indicating that this approach could yield valuable insights.
Where this research is happening
BOSTON, UNITED STATES
- MASSACHUSETTS GENERAL HOSPITAL — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FOULKES, ANDREA S — MASSACHUSETTS GENERAL HOSPITAL
- Study coordinator: FOULKES, ANDREA S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: adverse sequelae of coronavirus disease, adverse sequelae of coronavirus disease 2019